Leigh Anne Siino on The Spherix Global’s Translation of ASH25 Insights Into Actionable Intelligence
Leigh Anne Siino, Chief Revenue Officer at Spherix Global Insights, shared on LinkedIn:
”The Spherix Global Insights Hematology/Oncology team is translating key insights from ASH25 into actionable intelligence — helping strategy, commercial, and medical teams across pharma prepare for the next wave of change across benign and malignant hematology.
What we’re seeing and why it matters now:
Sickle Cell Disease: Turning Patient Voice and Data Into Advantage
SCD is entering a pivotal period, with growing emphasis on coordinated patient-level data and deeper incorporation of patient perspectives.
As pipelines advance and treatment options expand, organizations with timely, centralized insights will be best positioned to optimize targeting, prepare for launches, and align strategies with real-world care delivery.
Cross-Therapeutic Mechanisms and Gene Therapy in Benign Hematology
ASH underscored rising interest in therapies with shared mechanisms across conditions — including autoimmune cytopenias, SCD, hemophilia, and vWD — alongside continued focus on gene therapies.
These dynamics reinforce the need for cross-therapy intelligence to support faster, evidence-based decision-making as indications evolve.
Malignant Hematology: Next-Gen Modalities and Earlier-Line Opportunity
In malignant disease, advances in CAR-T platforms, expanding AML pipelines, and movement into earlier lines (including smoldering multiple myeloma) are reshaping both clinical and commercial landscapes.
Explore our latest and upcoming hematology publications on the Spherix Client Portal.”
All from ASH25 featured in Hemostasis Today.
-
May 23, 2026, 08:15Alexander Krupp: Asundexian Receives Priority Review Designation from China‘s NMPA
-
May 23, 2026, 07:59Toward a Dedicated Framework for MIg-Driven Hemostatic Disorders – JTH
-
May 23, 2026, 07:53Ankit Panthari: Can Haemophilia Serve as A Health System Model for Other Rare Diseases in India?
-
May 23, 2026, 07:43Ted Roh: Indonesia’s Plasma Fractionation Plant Wins Social Infrastructure Deal of the Year at the IJGlobal Awards 2025
-
May 23, 2026, 07:36Angie Read: Stories of Strength and Resilience on The Latest Episode of Stroke Sisters
-
May 23, 2026, 07:30Ozlem Fidanci: Reflections From WHA79 on the Future of Stroke Care
-
May 23, 2026, 07:21Ney Carter Borges: Where the Benefit Appears in Dual Antiplatelet Therapy
-
May 23, 2026, 05:38SIUH Advances Precision Stroke Care with Vena MicroAngioscope – Northwell Health
-
May 23, 2026, 05:31Kalyan Roy: Precision Blood Matching in Transfusion-Dependent Thalassaemia